Anglo-Swedish drugmaker AstraZeneca has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

Drugs giant AstraZeneca faces a landmark High Court battle over accusations that some doses of its Covid-19 vaccine were 'defective' and claims of its efficacy were 'vastly overstated'. Two test ...

Nov 14 (Reuters) - Drugmaker AstraZeneca (AZN.L) said on Tuesday its cancer drug Imfinzi given along with chemoradiotherapy (CRT) failed to meet its main goal in a late-stage trial to treat ...

AstraZeneca PLC (LSE:AZN) had a mixed day of news, with the bright spots of a foray into anti-obesity drugs and an upgrade to its full-year outlook somewhat clouded by news about potential lawsuits ...

AstraZeneca has agreed to pay up to $2 billion for an experimental pill used to treat obesity and type 2 diabetes—the latest pharmaceutical firm to bet on treatment similar to popular weight ...

Shares of AstraZeneca rose as much as 4.2% in early trade after the company raised its full-year guidance for core earnings per share and total revenue excluding Covid-19 medicines after beating ...

A former Playboy Playmate settled with The National Enquirer in a California state court Wednesday, releasing her from a contract agreement that she says blocked her from sharing her story of an ...

AstraZeneca is scheduled to report results for the third quarter of the year on Thursday. Here is what you need to know: SALES: The Anglo-Swedish pharmaceutical giant is expected to report revenue ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is ...